Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Readmission | 36 | 2023 | 3116 | 5.350 |
Why?
|
Myocardial Infarction | 38 | 2024 | 11718 | 3.970 |
Why?
|
Cardiology | 8 | 2021 | 1668 | 2.090 |
Why?
|
Referral and Consultation | 11 | 2020 | 3531 | 1.980 |
Why?
|
Medicare | 22 | 2024 | 6566 | 1.690 |
Why?
|
Patient Discharge | 15 | 2023 | 3318 | 1.560 |
Why?
|
Heart Valve Diseases | 6 | 2020 | 1074 | 1.530 |
Why?
|
Heart Failure | 19 | 2024 | 10895 | 1.500 |
Why?
|
Burnout, Professional | 4 | 2023 | 694 | 1.420 |
Why?
|
Echocardiography | 8 | 2023 | 5099 | 1.370 |
Why?
|
Remote Consultation | 3 | 2016 | 238 | 1.310 |
Why?
|
International Classification of Diseases | 5 | 2021 | 867 | 1.290 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2022 | 349 | 1.220 |
Why?
|
Delivery of Health Care, Integrated | 4 | 2020 | 941 | 1.180 |
Why?
|
Healthcare Disparities | 6 | 2021 | 3154 | 1.170 |
Why?
|
Uncertainty | 5 | 2022 | 735 | 1.130 |
Why?
|
Ambulatory Care | 6 | 2021 | 2708 | 1.110 |
Why?
|
Decision Support Techniques | 6 | 2021 | 1956 | 1.080 |
Why?
|
Acute Coronary Syndrome | 7 | 2022 | 2337 | 1.030 |
Why?
|
Hospital Costs | 6 | 2021 | 985 | 1.030 |
Why?
|
Telemedicine | 7 | 2022 | 2872 | 1.030 |
Why?
|
Quality Indicators, Health Care | 5 | 2020 | 1831 | 1.010 |
Why?
|
Medicaid | 8 | 2023 | 2737 | 1.000 |
Why?
|
Anterior Wall Myocardial Infarction | 2 | 2023 | 45 | 1.000 |
Why?
|
United States | 65 | 2024 | 69872 | 0.990 |
Why?
|
Patient Protection and Affordable Care Act | 6 | 2023 | 1209 | 0.980 |
Why?
|
Politics | 3 | 2021 | 791 | 0.950 |
Why?
|
Chest Pain | 7 | 2022 | 1114 | 0.890 |
Why?
|
Humans | 152 | 2024 | 744366 | 0.840 |
Why?
|
Aortic Valve | 3 | 2017 | 1924 | 0.800 |
Why?
|
Angina Pectoris | 4 | 2021 | 977 | 0.800 |
Why?
|
Quality Improvement | 6 | 2020 | 3749 | 0.780 |
Why?
|
Hospitalization | 16 | 2023 | 10259 | 0.770 |
Why?
|
American Heart Association | 3 | 2023 | 1057 | 0.770 |
Why?
|
Coronary Artery Disease | 9 | 2023 | 6486 | 0.750 |
Why?
|
Urinary Bladder, Overactive | 1 | 2022 | 106 | 0.750 |
Why?
|
Physicians | 4 | 2023 | 4567 | 0.740 |
Why?
|
Coronary Angiography | 8 | 2023 | 4576 | 0.740 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15160 | 0.730 |
Why?
|
Risk Assessment | 16 | 2023 | 23336 | 0.730 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2021 | 153 | 0.720 |
Why?
|
General Practitioners | 1 | 2021 | 103 | 0.710 |
Why?
|
Insurance Coverage | 5 | 2023 | 1900 | 0.710 |
Why?
|
Tricuspid Valve | 2 | 2019 | 403 | 0.690 |
Why?
|
Cost Savings | 5 | 2019 | 925 | 0.690 |
Why?
|
Practice Management | 1 | 2019 | 37 | 0.680 |
Why?
|
Hospitals | 10 | 2023 | 3954 | 0.680 |
Why?
|
Prescriptions | 1 | 2021 | 387 | 0.660 |
Why?
|
Foreign Medical Graduates | 1 | 2019 | 79 | 0.650 |
Why?
|
Cardiology Service, Hospital | 2 | 2020 | 246 | 0.640 |
Why?
|
Atrial Fibrillation | 6 | 2023 | 5035 | 0.630 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 857 | 0.620 |
Why?
|
Physicians, Primary Care | 2 | 2022 | 592 | 0.620 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2021 | 1537 | 0.620 |
Why?
|
Aged | 54 | 2024 | 163288 | 0.610 |
Why?
|
Urinary Incontinence | 1 | 2022 | 496 | 0.610 |
Why?
|
Male | 73 | 2024 | 350115 | 0.610 |
Why?
|
Public Health | 3 | 2021 | 2602 | 0.610 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2023 | 1265 | 0.600 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2018 | 397 | 0.600 |
Why?
|
Emergency Service, Hospital | 9 | 2021 | 7658 | 0.590 |
Why?
|
Female | 72 | 2024 | 380193 | 0.590 |
Why?
|
Diffusion of Innovation | 1 | 2022 | 725 | 0.590 |
Why?
|
Hospital Records | 1 | 2017 | 95 | 0.590 |
Why?
|
Heart Injuries | 1 | 2019 | 210 | 0.590 |
Why?
|
Episode of Care | 1 | 2018 | 126 | 0.590 |
Why?
|
Mitral Valve Insufficiency | 4 | 2022 | 1421 | 0.590 |
Why?
|
Delivery of Health Care | 7 | 2022 | 5321 | 0.590 |
Why?
|
Length of Stay | 10 | 2021 | 6311 | 0.590 |
Why?
|
Office Visits | 3 | 2015 | 598 | 0.580 |
Why?
|
Health Services Misuse | 1 | 2019 | 243 | 0.580 |
Why?
|
Defibrillators, Implantable | 2 | 2023 | 1440 | 0.570 |
Why?
|
Benchmarking | 2 | 2020 | 1042 | 0.560 |
Why?
|
Morphine | 2 | 2017 | 657 | 0.560 |
Why?
|
Aged, 80 and over | 28 | 2024 | 57776 | 0.560 |
Why?
|
Ventricular Function, Left | 3 | 2024 | 3666 | 0.560 |
Why?
|
Poverty | 4 | 2023 | 2660 | 0.550 |
Why?
|
Troponin T | 1 | 2021 | 754 | 0.550 |
Why?
|
Neprilysin | 1 | 2019 | 439 | 0.550 |
Why?
|
Subacute Care | 1 | 2018 | 168 | 0.550 |
Why?
|
Islam | 1 | 2016 | 69 | 0.540 |
Why?
|
Stroke Volume | 5 | 2024 | 5006 | 0.540 |
Why?
|
Patient Care Management | 1 | 2019 | 306 | 0.540 |
Why?
|
Registries | 8 | 2022 | 8091 | 0.530 |
Why?
|
Patient Identification Systems | 1 | 2016 | 79 | 0.530 |
Why?
|
Health Care Costs | 7 | 2023 | 3208 | 0.530 |
Why?
|
Consumer Health Information | 1 | 2018 | 211 | 0.520 |
Why?
|
Reimbursement, Incentive | 2 | 2018 | 540 | 0.520 |
Why?
|
Patient Admission | 2 | 2020 | 1380 | 0.510 |
Why?
|
Endocarditis | 1 | 2019 | 349 | 0.510 |
Why?
|
Hyperlipidemias | 1 | 2019 | 789 | 0.500 |
Why?
|
Quality Assurance, Health Care | 2 | 2015 | 2212 | 0.490 |
Why?
|
Electronic Health Records | 5 | 2022 | 4468 | 0.490 |
Why?
|
Health Status Indicators | 1 | 2020 | 970 | 0.490 |
Why?
|
Risk Adjustment | 1 | 2018 | 594 | 0.490 |
Why?
|
Drug Costs | 1 | 2022 | 1105 | 0.490 |
Why?
|
Parenting | 1 | 2020 | 679 | 0.480 |
Why?
|
Physicians, Women | 1 | 2020 | 486 | 0.470 |
Why?
|
Program Evaluation | 7 | 2020 | 2488 | 0.470 |
Why?
|
Aortic Valve Stenosis | 3 | 2021 | 1965 | 0.470 |
Why?
|
Myocardial Ischemia | 2 | 2022 | 2148 | 0.470 |
Why?
|
Middle Aged | 45 | 2023 | 213390 | 0.470 |
Why?
|
Policy Making | 1 | 2018 | 554 | 0.460 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 695 | 0.460 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 432 | 0.460 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 855 | 0.450 |
Why?
|
Severity of Illness Index | 7 | 2021 | 15535 | 0.450 |
Why?
|
Survival Rate | 6 | 2021 | 12788 | 0.440 |
Why?
|
Propensity Score | 2 | 2019 | 1781 | 0.440 |
Why?
|
Exercise Test | 2 | 2018 | 2073 | 0.440 |
Why?
|
Massachusetts | 7 | 2023 | 8662 | 0.440 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1405 | 0.430 |
Why?
|
Practice Guidelines as Topic | 6 | 2019 | 7282 | 0.420 |
Why?
|
Social Responsibility | 1 | 2015 | 388 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.420 |
Why?
|
Internal Medicine | 1 | 2019 | 1009 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.410 |
Why?
|
Patient Care Team | 2 | 2020 | 2531 | 0.410 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1257 | 0.410 |
Why?
|
Medical Errors | 1 | 2020 | 1297 | 0.400 |
Why?
|
Income | 2 | 2021 | 1913 | 0.400 |
Why?
|
Patient Participation | 2 | 2020 | 1457 | 0.400 |
Why?
|
United States Department of Veterans Affairs | 1 | 2016 | 875 | 0.390 |
Why?
|
Risk Factors | 22 | 2023 | 72296 | 0.390 |
Why?
|
Time Factors | 15 | 2021 | 40075 | 0.390 |
Why?
|
Sex Factors | 4 | 2019 | 10400 | 0.380 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 1078 | 0.380 |
Why?
|
Postoperative Complications | 7 | 2021 | 15297 | 0.380 |
Why?
|
Inpatients | 3 | 2021 | 2518 | 0.370 |
Why?
|
Fasting | 1 | 2016 | 1592 | 0.370 |
Why?
|
Outpatients | 4 | 2021 | 1487 | 0.360 |
Why?
|
Endocrinology | 1 | 2016 | 443 | 0.360 |
Why?
|
Mitral Valve | 2 | 2021 | 1491 | 0.360 |
Why?
|
Retrospective Studies | 28 | 2023 | 77460 | 0.340 |
Why?
|
Health Services Accessibility | 4 | 2023 | 5135 | 0.340 |
Why?
|
Disclosure | 1 | 2015 | 736 | 0.340 |
Why?
|
Heart Valve Prosthesis | 1 | 2017 | 1490 | 0.330 |
Why?
|
Electric Countershock | 3 | 2021 | 534 | 0.320 |
Why?
|
Job Satisfaction | 2 | 2023 | 534 | 0.320 |
Why?
|
Thoracic Surgery | 1 | 2015 | 719 | 0.320 |
Why?
|
Heart Diseases | 2 | 2019 | 2789 | 0.320 |
Why?
|
Anticoagulants | 5 | 2023 | 4600 | 0.310 |
Why?
|
Pilot Projects | 5 | 2022 | 8319 | 0.300 |
Why?
|
Kidney Diseases | 1 | 2019 | 2148 | 0.300 |
Why?
|
New England | 2 | 2024 | 1022 | 0.300 |
Why?
|
Pneumonia | 5 | 2019 | 2133 | 0.290 |
Why?
|
Primary Prevention | 1 | 2014 | 1167 | 0.290 |
Why?
|
Vascular Diseases | 1 | 2015 | 1161 | 0.290 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2017 | 2073 | 0.280 |
Why?
|
Stroke | 5 | 2022 | 9981 | 0.280 |
Why?
|
Cardiac Surgical Procedures | 2 | 2019 | 3537 | 0.280 |
Why?
|
Predictive Value of Tests | 7 | 2023 | 15078 | 0.270 |
Why?
|
Treatment Outcome | 19 | 2022 | 63107 | 0.270 |
Why?
|
Algorithms | 4 | 2024 | 13882 | 0.270 |
Why?
|
Patient Preference | 3 | 2018 | 889 | 0.270 |
Why?
|
Comorbidity | 6 | 2024 | 10388 | 0.260 |
Why?
|
Stress, Psychological | 2 | 2019 | 4245 | 0.260 |
Why?
|
Forecasting | 3 | 2019 | 2951 | 0.250 |
Why?
|
Prognosis | 8 | 2019 | 29060 | 0.250 |
Why?
|
Quality of Health Care | 3 | 2023 | 4369 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3255 | 0.250 |
Why?
|
Fee-for-Service Plans | 2 | 2019 | 694 | 0.240 |
Why?
|
Guideline Adherence | 3 | 2019 | 2265 | 0.240 |
Why?
|
Coronary Vessels | 1 | 2015 | 3107 | 0.240 |
Why?
|
Minority Groups | 2 | 2018 | 1221 | 0.230 |
Why?
|
Mentors | 1 | 2009 | 631 | 0.230 |
Why?
|
Aortic Valve Insufficiency | 2 | 2018 | 579 | 0.230 |
Why?
|
Continuity of Patient Care | 2 | 2021 | 1049 | 0.230 |
Why?
|
Survival Analysis | 4 | 2019 | 10252 | 0.230 |
Why?
|
Self Care | 2 | 2020 | 786 | 0.220 |
Why?
|
Decision Making | 1 | 2017 | 3888 | 0.220 |
Why?
|
Cost-Benefit Analysis | 5 | 2022 | 5388 | 0.220 |
Why?
|
Hospital Mortality | 5 | 2021 | 5316 | 0.210 |
Why?
|
Population Groups | 1 | 2023 | 209 | 0.210 |
Why?
|
Biomedical Research | 1 | 2018 | 3309 | 0.210 |
Why?
|
Odds Ratio | 5 | 2018 | 9849 | 0.210 |
Why?
|
Veterans | 1 | 2016 | 2519 | 0.210 |
Why?
|
Hospitals, General | 2 | 2017 | 749 | 0.210 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2024 | 340 | 0.200 |
Why?
|
Physician-Patient Relations | 3 | 2021 | 3229 | 0.200 |
Why?
|
Triage | 2 | 2020 | 977 | 0.200 |
Why?
|
Subtilisins | 1 | 2021 | 83 | 0.200 |
Why?
|
Policy | 2 | 2023 | 508 | 0.200 |
Why?
|
Boston | 3 | 2020 | 9312 | 0.190 |
Why?
|
Troponin | 2 | 2022 | 524 | 0.180 |
Why?
|
Health Care Reform | 2 | 2021 | 1261 | 0.180 |
Why?
|
Brugada Syndrome | 1 | 2021 | 97 | 0.180 |
Why?
|
Databases, Factual | 7 | 2021 | 7730 | 0.180 |
Why?
|
Feasibility Studies | 3 | 2020 | 5077 | 0.180 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2023 | 289 | 0.170 |
Why?
|
Coronary Disease | 1 | 2014 | 6077 | 0.170 |
Why?
|
Electronics, Medical | 1 | 2019 | 71 | 0.170 |
Why?
|
Cardiac Tamponade | 1 | 2020 | 173 | 0.170 |
Why?
|
Academic Medical Centers | 3 | 2022 | 2760 | 0.170 |
Why?
|
Economics, Hospital | 2 | 2018 | 213 | 0.170 |
Why?
|
Cause of Death | 2 | 2020 | 3582 | 0.170 |
Why?
|
Pericarditis | 1 | 2020 | 128 | 0.170 |
Why?
|
Diagnosis-Related Groups | 1 | 2020 | 455 | 0.170 |
Why?
|
Observer Variation | 2 | 2015 | 2593 | 0.170 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2020 | 236 | 0.170 |
Why?
|
Warfarin | 3 | 2023 | 1497 | 0.160 |
Why?
|
Incidence | 7 | 2021 | 20952 | 0.160 |
Why?
|
Social Values | 1 | 2019 | 224 | 0.160 |
Why?
|
Pericardial Effusion | 1 | 2020 | 247 | 0.160 |
Why?
|
Attitude of Health Personnel | 3 | 2018 | 3841 | 0.160 |
Why?
|
Follow-Up Studies | 9 | 2021 | 39052 | 0.160 |
Why?
|
Dyslipidemias | 2 | 2022 | 849 | 0.150 |
Why?
|
Logistic Models | 4 | 2023 | 13409 | 0.150 |
Why?
|
Cohort Studies | 6 | 2022 | 40559 | 0.150 |
Why?
|
Aftercare | 1 | 2023 | 870 | 0.150 |
Why?
|
General Surgery | 1 | 2009 | 1636 | 0.150 |
Why?
|
Pandemics | 4 | 2021 | 8385 | 0.150 |
Why?
|
Mandatory Reporting | 1 | 2018 | 121 | 0.150 |
Why?
|
Arteritis | 1 | 2019 | 159 | 0.150 |
Why?
|
Coronary Stenosis | 1 | 2023 | 834 | 0.150 |
Why?
|
Clinical Coding | 1 | 2018 | 171 | 0.150 |
Why?
|
Ownership | 1 | 2019 | 332 | 0.150 |
Why?
|
Age Factors | 3 | 2021 | 18373 | 0.150 |
Why?
|
Reimbursement Mechanisms | 2 | 2020 | 670 | 0.150 |
Why?
|
Health Priorities | 1 | 2020 | 380 | 0.140 |
Why?
|
Health Policy | 2 | 2020 | 2661 | 0.140 |
Why?
|
Respiratory Tract Diseases | 1 | 2022 | 722 | 0.140 |
Why?
|
Demography | 1 | 2021 | 1655 | 0.140 |
Why?
|
History, 21st Century | 2 | 2015 | 1534 | 0.140 |
Why?
|
Substance Abuse, Intravenous | 2 | 2019 | 525 | 0.140 |
Why?
|
Critical Pathways | 2 | 2019 | 476 | 0.140 |
Why?
|
Mortality | 4 | 2020 | 2864 | 0.130 |
Why?
|
Nitrates | 1 | 2017 | 265 | 0.130 |
Why?
|
Natural Language Processing | 1 | 2023 | 1041 | 0.130 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 935 | 0.130 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 789 | 0.130 |
Why?
|
Secondary Prevention | 1 | 2021 | 1530 | 0.120 |
Why?
|
Program Development | 2 | 2019 | 1316 | 0.120 |
Why?
|
Bayes Theorem | 2 | 2022 | 2307 | 0.120 |
Why?
|
Angina, Unstable | 1 | 2019 | 926 | 0.120 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 25039 | 0.120 |
Why?
|
Insurance, Health | 3 | 2021 | 2494 | 0.120 |
Why?
|
Causality | 1 | 2021 | 1275 | 0.120 |
Why?
|
Principal Component Analysis | 1 | 2017 | 940 | 0.120 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 950 | 0.120 |
Why?
|
Risk Reduction Behavior | 2 | 2022 | 1125 | 0.120 |
Why?
|
History, 20th Century | 2 | 2015 | 2740 | 0.120 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2017 | 367 | 0.120 |
Why?
|
Consensus | 1 | 2023 | 2960 | 0.120 |
Why?
|
Social Class | 2 | 2022 | 1997 | 0.120 |
Why?
|
Canada | 1 | 2019 | 2065 | 0.120 |
Why?
|
Medical Records | 2 | 2018 | 1413 | 0.120 |
Why?
|
Morbidity | 2 | 2017 | 1768 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20130 | 0.110 |
Why?
|
Students, Medical | 1 | 2006 | 1862 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9955 | 0.110 |
Why?
|
Government Regulation | 1 | 2018 | 522 | 0.110 |
Why?
|
Discriminant Analysis | 1 | 2013 | 235 | 0.110 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1504 | 0.110 |
Why?
|
Hypertension | 2 | 2023 | 8479 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 412 | 0.110 |
Why?
|
Health Literacy | 1 | 2018 | 414 | 0.110 |
Why?
|
Coronary Care Units | 1 | 2014 | 214 | 0.110 |
Why?
|
Vasodilator Agents | 1 | 2017 | 976 | 0.110 |
Why?
|
Coronary Artery Bypass | 2 | 2021 | 2288 | 0.110 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2018 | 554 | 0.100 |
Why?
|
Gastroenterology | 1 | 2018 | 538 | 0.100 |
Why?
|
Vaccination | 1 | 2004 | 3279 | 0.100 |
Why?
|
Emergency Medicine | 2 | 2019 | 1205 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1519 | 0.100 |
Why?
|
Interviews as Topic | 1 | 2018 | 2539 | 0.100 |
Why?
|
Amygdala | 1 | 2019 | 1315 | 0.100 |
Why?
|
Seasons | 1 | 2017 | 1493 | 0.100 |
Why?
|
Medicine | 1 | 2020 | 946 | 0.100 |
Why?
|
Self Report | 1 | 2022 | 3553 | 0.100 |
Why?
|
Prospective Studies | 6 | 2023 | 53290 | 0.100 |
Why?
|
Analgesics, Opioid | 2 | 2017 | 3677 | 0.100 |
Why?
|
Longitudinal Studies | 3 | 2023 | 13991 | 0.090 |
Why?
|
Drug Hypersensitivity | 1 | 2019 | 884 | 0.090 |
Why?
|
Particulate Matter | 1 | 2022 | 2529 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2282 | 0.090 |
Why?
|
Peripheral Arterial Disease | 2 | 2018 | 1188 | 0.090 |
Why?
|
Motivation | 1 | 2020 | 1971 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2019 | 2050 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1170 | 0.090 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1438 | 0.090 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2004 | 3338 | 0.090 |
Why?
|
Myocardial Revascularization | 1 | 2014 | 841 | 0.090 |
Why?
|
Emergency Medical Services | 1 | 2021 | 1917 | 0.080 |
Why?
|
Checklist | 1 | 2016 | 833 | 0.080 |
Why?
|
Prevalence | 3 | 2022 | 15221 | 0.080 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12356 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1164 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1622 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2020 | 19905 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7147 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14723 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2022 | 3265 | 0.080 |
Why?
|
Reoperation | 2 | 2016 | 4201 | 0.080 |
Why?
|
Regression Analysis | 1 | 2017 | 6459 | 0.080 |
Why?
|
Paresthesia | 1 | 2008 | 161 | 0.080 |
Why?
|
Environmental Exposure | 1 | 2022 | 4232 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7785 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2014 | 2453 | 0.070 |
Why?
|
Adult | 10 | 2022 | 214052 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5953 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 1968 | 0.070 |
Why?
|
Obesity | 3 | 2024 | 12746 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5749 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2278 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3444 | 0.070 |
Why?
|
Data Collection | 1 | 2015 | 3339 | 0.070 |
Why?
|
Electrocardiography | 2 | 2021 | 6442 | 0.070 |
Why?
|
Risk | 1 | 2018 | 9688 | 0.070 |
Why?
|
Disease Management | 1 | 2016 | 2460 | 0.060 |
Why?
|
Health Expenditures | 1 | 2018 | 2349 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2535 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4557 | 0.060 |
Why?
|
Quality of Life | 3 | 2023 | 12802 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 5984 | 0.060 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2004 | 66 | 0.060 |
Why?
|
Venous Thromboembolism | 1 | 2016 | 1671 | 0.060 |
Why?
|
Diuresis | 1 | 2023 | 116 | 0.060 |
Why?
|
Food Handling | 1 | 2023 | 145 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13286 | 0.060 |
Why?
|
Asthma | 1 | 2022 | 6010 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3395 | 0.060 |
Why?
|
Catheter Ablation | 1 | 2016 | 2758 | 0.050 |
Why?
|
Costs and Cost Analysis | 2 | 2019 | 1680 | 0.050 |
Why?
|
Denmark | 1 | 2004 | 738 | 0.050 |
Why?
|
Fast Foods | 1 | 2023 | 197 | 0.050 |
Why?
|
Censuses | 1 | 2022 | 200 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 21748 | 0.050 |
Why?
|
Benzylamines | 1 | 2022 | 223 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3508 | 0.050 |
Why?
|
Uracil | 1 | 2022 | 165 | 0.050 |
Why?
|
Cross-Cultural Comparison | 1 | 2004 | 651 | 0.050 |
Why?
|
Infarction | 1 | 2022 | 244 | 0.050 |
Why?
|
Headache | 1 | 2008 | 1226 | 0.050 |
Why?
|
Ambulances | 1 | 2021 | 95 | 0.050 |
Why?
|
Australia | 1 | 2023 | 1167 | 0.050 |
Why?
|
Chronic Disease | 1 | 2015 | 9145 | 0.050 |
Why?
|
Diuretics | 1 | 2023 | 591 | 0.050 |
Why?
|
Pregnancy | 1 | 2022 | 29144 | 0.040 |
Why?
|
Patients | 1 | 2006 | 900 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1107 | 0.040 |
Why?
|
Flavonoids | 1 | 2003 | 443 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 11726 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11525 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12244 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 314 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 551 | 0.040 |
Why?
|
Young Adult | 3 | 2020 | 56429 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 550 | 0.040 |
Why?
|
Allergy and Immunology | 1 | 2019 | 169 | 0.040 |
Why?
|
Models, Economic | 1 | 2021 | 712 | 0.040 |
Why?
|
Penicillins | 1 | 2019 | 380 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2029 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 680 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1180 | 0.030 |
Why?
|
Insurance | 1 | 2017 | 111 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1660 | 0.030 |
Why?
|
Prospective Payment System | 1 | 2016 | 133 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1683 | 0.030 |
Why?
|
New York | 1 | 2017 | 886 | 0.030 |
Why?
|
Piperidines | 1 | 2003 | 1602 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2009 | 3079 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2016 | 585 | 0.030 |
Why?
|
California | 1 | 2017 | 1402 | 0.030 |
Why?
|
Panic Disorder | 1 | 2016 | 616 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2003 | 3203 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2919 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1739 | 0.030 |
Why?
|
Perioperative Care | 1 | 2020 | 1002 | 0.030 |
Why?
|
Sex Distribution | 1 | 2017 | 2297 | 0.030 |
Why?
|
Allergens | 1 | 2019 | 1320 | 0.030 |
Why?
|
Pyridones | 1 | 2016 | 711 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2015 | 417 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2926 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 3914 | 0.020 |
Why?
|
Dyspnea | 1 | 2018 | 1303 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 2016 | 0.020 |
Why?
|
Health Promotion | 1 | 2022 | 2205 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2019 | 2073 | 0.020 |
Why?
|
Labetalol | 1 | 2008 | 30 | 0.020 |
Why?
|
Sural Nerve | 1 | 2008 | 106 | 0.020 |
Why?
|
Amlodipine | 1 | 2008 | 83 | 0.020 |
Why?
|
Air Pollution | 1 | 2022 | 2286 | 0.020 |
Why?
|
Air Pollutants | 1 | 2022 | 2816 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 12961 | 0.020 |
Why?
|
Guanine | 1 | 2008 | 274 | 0.020 |
Why?
|
Hemorrhage | 1 | 2018 | 3461 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 1972 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6539 | 0.020 |
Why?
|
Diet | 1 | 2023 | 7937 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2690 | 0.020 |
Why?
|
Child | 2 | 2022 | 77709 | 0.020 |
Why?
|
Stents | 1 | 2016 | 3282 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8340 | 0.020 |
Why?
|
Vasculitis | 1 | 2008 | 519 | 0.020 |
Why?
|
Smoking | 1 | 2021 | 8987 | 0.010 |
Why?
|
Prednisone | 1 | 2008 | 1574 | 0.010 |
Why?
|
Inflammation | 1 | 2003 | 10637 | 0.010 |
Why?
|
Hepatitis B | 1 | 2008 | 695 | 0.010 |
Why?
|
Thrombosis | 1 | 2016 | 2968 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2008 | 1381 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 85779 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2003 | 13693 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 41005 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2003 | 671 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2016 | 4266 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4639 | 0.010 |
Why?
|
Depression | 1 | 2018 | 7759 | 0.010 |
Why?
|
Interleukins | 1 | 2003 | 791 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6489 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2274 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6755 | 0.010 |
Why?
|
Neoplasms | 1 | 2003 | 21696 | 0.010 |
Why?
|
Bone Marrow | 1 | 2003 | 2948 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35425 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3799 | 0.010 |
Why?
|